You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019110
Jan 202012120
Feb 202021215
Mar 202026262
Apr 202034345
May 202027277
Jun 202039395
Jul 202021215
Aug 2020282814
Sep 2020252510
Oct 2020272711
Nov 2020414118
Dec 2020373713
Jan 2021555521
Feb 202134347
Mar 2021404013
Apr 2021424117
May 2021313120
Jun 2021818125
Jul 2021535322
Aug 2021373912
Sep 2021595923
Oct 2021505232
Nov 2021454532
Dec 2021778330
Jan 2022646841
Feb 2022394020
Mar 2022697126
Apr 2022787831
May 202213113131
Jun 2022575813
Jul 2022414223
Aug 2022555818
Sep 2022323519
Oct 2022687338
Nov 2022565929
Dec 2022383818
Jan 2023616113
Feb 2023252717
Mar 2023394221
Apr 2023313516
May 2023313124
Jun 2023323239
Jul 2023393916
Aug 202317178
Sep 202319198
Oct 202332329
Nov 202312312415
Dec 2023414119
Jan 2024333317
Feb 2024333315
Mar 2024282856
Apr 2024282926
May 2024292914
Jun 2024333320
Jul 2024424323
Aug 2024232539
Sep 2024191923
Oct 2024262636
Nov 2024242522
Dec 202437378
Jan 2025383820
Feb 202519719715
Mar 2025262628
Apr 2025424315
May 2025272733
Jun 2025171710
Total286329111281